Loading clinical trials...
Loading clinical trials...
An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage
Conditions
Interventions
A-101 Topical Solution
Locations
3
United States
Aclaris Investigational Site
Fort Washington, Pennsylvania, United States
Aclaris Investigational Site
Knoxville, Tennessee, United States
Aclaris Investigational Site
Austin, Texas, United States
Start Date
March 21, 2018
Primary Completion Date
November 14, 2018
Completion Date
November 14, 2018
Last Updated
October 2, 2019
NCT06108024
NCT07441538
NCT04249115
NCT03846531
NCT00540566
NCT01986920
Lead Sponsor
Aclaris Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions